N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide

C152H145F9N18O7 — CID 159709844

About N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide

N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide (PubChem CID 159709844) has the molecular formula C152H145F9N18O7 and a molecular weight of 2506.93 g/mol. Its IUPAC name is N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide.

Molecular Properties

• Compound Name: N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
• PubChem CID: 159709844
• Molecular Formula: C152H145F9N18O7
• Molecular Weight: 2506.93 g/mol
• Exact Mass: 2505.14
• IUPAC Name: N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
• SMILES: CCc1ccc(-c2cccnc2[C@@H](Cc2ccccc2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c(C)c1.Cc1ccccc1-c1cccnc1[C@@H](Cc1ccccc1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.Cc1ccccc1-c1cccnc1[C@H](Cc1ccccc1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
• InChI: InChI=1S/C32H33F3N4O.2C30H29F3N4O.2C30H27N3O2/c1-3-22-15-16-24(21(2)18-22)25-13-9-17-36-30(25)27(19-23-10-5-4-6-11-23)37-29(40)20-39-28-14-8-7-12-26(28)31(38-39)32(33,34)35;2*1-20-10-5-6-13-22(20)23-15-9-17-34-28(23)25(18-21-11-3-2-4-12-21)35-27(38)19-37-26-16-8-7-14-24(26)29(36-37)30(31,32)33;2*1-20-8-5-6-11-24(20)25-12-7-15-31-30(25)28(16-21-9-3-2-4-10-21)33-29(35)17-22-19-32-27-14-13-23(34)18-26(22)27/h4-6,9-11,13,15-18,27H,3,7-8,12,14,19-20H2,1-2H3,(H,37,40);2*2-6,9-13,15,17,25H,7-8,14,16,18-19H2,1H3,(H,35,38);2*2-15,18-19,28,32,34H,16-17H2,1H3,(H,33,35)/t27-;2*25-;2*28-/m11010/s1
• InChIKey: MYRPTZLSPCDLRK-TWGDAGHPSA-N
• XLogP: 31.09
• TPSA: 335.45 Ų
• H-Bond Donors: 9
• H-Bond Acceptors: 18
• Rotatable Bonds: 36
• Heavy Atoms: 186
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2506.93
LogP ≤ 5	31.09
H-Bond Donors ≤ 5	9
H-Bond Acceptors ≤ 10	18

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?

The IUPAC name of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide (CID 159709844) is N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide.

What is the SMILES notation for N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?

The canonical SMILES for N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide is CCc1ccc(-c2cccnc2[C@@H](Cc2ccccc2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c(C)c1.Cc1ccccc1-c1cccnc1[C@@H](Cc1ccccc1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.Cc1ccccc1-c1cccnc1[C@H](Cc1ccccc1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.

What is the InChIKey of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?

The InChIKey is MYRPTZLSPCDLRK-TWGDAGHPSA-N. The full InChI is InChI=1S/C32H33F3N4O.2C30H29F3N4O.2C30H27N3O2/c1-3-22-15-16-24(21(2)18-22)25-13-9-17-36-30(25)27(19-23-10-5-4-6-11-23)37-29(40)20-39-28-14-8-7-12-26(28)31(38-39)32(33,34)35;2*1-20-10-5-6-13-22(20)23-15-9-17-34-28(23)25(18-21-11-3-2-4-12-21)35-27(38)19-37-26-16-8-7-14-24(26)29(36-37)30(31,32)33;2*1-20-8-5-6-11-24(20)25-12-7-15-31-30(25)28(16-21-9-3-2-4-10-21)33-29(35)17-22-19-32-27-14-13-23(34)18-26(22)27/h4-6,9-11,13,15-18,27H,3,7-8,12,14,19-20H2,1-2H3,(H,37,40);2*2-6,9-13,15,17,25H,7-8,14,16,18-19H2,1H3,(H,35,38);2*2-15,18-19,28,32,34H,16-17H2,1H3,(H,33,35)/t27-;2*25-;2*28-/m11010/s1.

What are the key properties of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?

N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide has a molecular weight of 2506.93 g/mol, XLogP of 31.09, 36 rotatable bonds, 9 hydrogen bond donors, and 18 hydrogen bond acceptors.

Where does this data come from?

All data for N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;2-(5-hydroxy-1H-indol-3-yl)-N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]acetamide;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide is sourced from PubChem (CID 159709844), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).